Foley Advises Highlander Partners on Sale of Profile Custom Extrusions

21 July 2021 Media Contact: Jen Dilworth News

Foley & Lardner LLP announced today it served as legal counsel for its Dallas-based private investment firm client, Highlander Partners, L.P., in the sale of Profile Customer Extrusions, LLC (“Profile”), a U.S. manufacturer of extruded aluminum, to KPS Capital Partners, LP (“KPS”), a global private equity firm with investing expertise across a range of manufacturing industries.

Profile provides a variety of custom extruded aluminum profiles to diverse end-markets, including residential and commercial construction, HVAC, hurricane protection, transportation, electrical, and marine. Through this sale, Profile will be combined alongside KPS’ acquisition of another global manufacturer of extruded aluminum, Metra Holding S.p.A. and Metra S.p.A.

Since its founding in 2004, Highlander Partners has completed over 80 majority control transactions in eight countries throughout North America and Europe for transaction values exceeding $3 billion, as well as direct minority investments throughout Asia.

Highlander acquired Profile under its portfolio in 2014, and its sale of Profile closed on July 14, 2021. The financial terms of the transaction were not disclosed.

The Foley deal team was led by partners Christopher Babcock and Alan Perkins and included associate Molly Richey.

Related Services


Podcast Episode 56: All Things Summer Associate Recruiting
30 July 2021
Foley Career Perspectives
Foley Podcast to Live Panel Discussion
29 July 2021
Foley Career Perspectives
End In Sight for Auto Shortage? Not So Fast
29 July 2021
Dashboard Insights
Legal Updates: Proposed Legislation for Private Foundation Minimum Distribution Requirements
28 July 2021
Legal News: Family Offices
30th Annual Law of Product Distribution & Franchise Seminar
29 September | 7 & 20 October 2021
Milwaukee | Chicago | Dallas
7th National Telehealth Summit
4-5 October 2021
Miami Beach, FL
AHLA Fraud & Compliance Forum
21-22 September 2021
Baltimore, MD
2nd Clinical Trial Agreements Forum
16-17 September 2021
Online Livestream